Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers

被引：12
|
作者：
Gevensleben, Heidrun [1 ]
Bossung, Verena [2 ,3 ]
Meindl, Alfons [4 ]
Wappenschmidt, Barbara [2 ]
de Gregorio, Nikolaus [5 ]
Osorio, Ana [6 ]
Romero, Atocha [7 ]
Buettner, Reinhard [8 ]
Markiefka, Birgid [8 ]
Schmutzler, Rita Katharina [2 ]
机构：
[1] Univ Hosp Bonn, Inst Pathol, D-53127 Bonn, Germany
[2] Univ Hosp Cologne, Dept Obstet Gynecol, Cologne, Germany
[3] Univ Hosp Luebeck, Dept Obstet & Gynecol, Lubeck, Germany
[4] Tech Univ Muenchen, Klinikum Rechts Isar, Div Tumor Genet, Dept Obstet & Gynecol, Munich, Germany
[5] Univ Hosp Ulm, Dept Obstet & Gynecol, Ulm, Germany
[6] Spanish Natl Canc Res Ctr, Human Genet Grp, Human Canc Genet Programme, Madrid, Spain
[7] Hosp Clin San Carlos, Dept Med Oncol, Madrid, Spain
[8] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷 / 03期
关键词：
BRCA1;
D O I：
10.1007/s00428-014-1619-1
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：365 / 369
页数：5
相关论文
共 50 条
  • [1] Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers
    Heidrun Gevensleben
    Verena Bossung
    Alfons Meindl
    Barbara Wappenschmidt
    Nikolaus de Gregorio
    Ana Osorio
    Atocha Romero
    Reinhard Buettner
    Birgid Markiefka
    Rita Katharina Schmutzler
    Virchows Archiv, 2014, 465 : 365 - 369
  • [2] RAD51C germline mutations in breast and ovarian cancer patients
    Mohammad R Akbari
    Patricia Tonin
    William D Foulkes
    Parviz Ghadirian
    Marc Tischkowitz
    Steven A Narod
    Breast Cancer Research, 12
  • [3] RAD51C germline mutations in breast and ovarian cancer patients
    Akbari, Mohammad R.
    Tonin, Patricia
    Foulkes, William D.
    Ghadirian, Parviz
    Tischkowitz, Marc
    Narod, Steven A.
    BREAST CANCER RESEARCH, 2010, 12 (04):
  • [4] Germline RAD51C mutations in ovarian cancer susceptibility
    Coulet, F.
    Fajac, A.
    Colas, C.
    Eyries, M.
    Dion-Miniere, A.
    Rouzier, R.
    Uzan, S.
    Lefranc, J-P
    Carbonnel, M.
    Cornelis, F.
    Cortez, A.
    Soubrier, F.
    CLINICAL GENETICS, 2013, 83 (04) : 332 - 336
  • [5] RAD51C and RAD51D germline mutations are associated to susceptibility to multiple cancers
    Boni, Jacopo
    Idani, Aida
    Weber, Evan
    Tomiak, Eva
    Foulkes, William
    el Haffaf, Zaki
    Rivera, Barbara
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 426 - 426
  • [6] Germline RAD51C mutations confer susceptibility to ovarian cancer
    Loveday, Chey
    Turnbull, Clare
    Ruark, Elise
    Xicola, Rosa Maria Munoz
    Ramsay, Emma
    Hughes, Deborah
    Warren-Perry, Margaret
    Snape, Katie
    Eccles, Diana
    Evans, D. Gareth
    Gore, Martin
    Renwick, Anthony
    Seal, Sheila
    Antoniou, Antonis C.
    Rahman, Nazneen
    NATURE GENETICS, 2012, 44 (05) : 475 - 476
  • [7] Germline RAD51C mutations confer susceptibility to ovarian cancer
    Alfons Meindl
    Katharina Eirich
    Stefanie Engert
    Alexandra Becker
    Daniela Endt
    Nina Ditsch
    Rita K Schmutzler
    Detlev Schindler
    Nature Genetics, 2012, 44 : 476 - 476
  • [8] Germline RAD51C mutations confer susceptibility to ovarian cancer
    Chey Loveday
    Clare Turnbull
    Elise Ruark
    Rosa Maria Munoz Xicola
    Emma Ramsay
    Deborah Hughes
    Margaret Warren-Perry
    Katie Snape
    Diana Eccles
    D Gareth Evans
    Martin Gore
    Anthony Renwick
    Sheila Seal
    Antonis C Antoniou
    Nazneen Rahman
    Nature Genetics, 2012, 44 : 475 - 476
  • [9] Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan
    Rashid, Muhammad U.
    Muhammad, Noor
    Faisal, Saima
    Amin, Asim
    Hamann, Ute
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (03) : 775 - 784
  • [10] Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan
    Muhammad U. Rashid
    Noor Muhammad
    Saima Faisal
    Asim Amin
    Ute Hamann
    Breast Cancer Research and Treatment, 2014, 145 : 775 - 784
12345